The Drug Industry: GlaxoSmithKline, Merck and Novartis Again Rank Highest on Access to Poor

The New York Times reports:

GlaxoSmithKline, Merck and Novartis have taken the top three spots again on the Access to Medicine Index, which ranks pharmaceutical companies on how readily they make their products available to the world’s poor.

It was the second time the rankings, which were created in 2008, have been issued. This time, 95 percent of the brand-name companies approached by the Dutch foundation that started the index agreed to provide information; two years ago, only about half did.